News New Biopharma Manufacturing Company Founded by Booth Alum Robert Nelsen Raises $800 Million RESILIENCE (National Resilience, Inc.) is a new company founded by University of Chicago Booth School of Business alum Robert Nelsen, MBA ’87 – with a commitment to tackling some of...
News Liv Labs Lands SBIR Grant and Spot in Y Combinator as it Develops a Better Tool for Women Experiencing Urinary Incontinence Urinary incontinence is a common ailment among women that often goes unspoken – and therefore untreated. One in four U.S. women, and 40% of women over age 65, experience unwelcome...
News SeedCon 2021: Resilience and Opportunity 2020 was a year unlike any other. The effects of COVID-19 reverberated across the world and while the challenges each industry faced were different, similar themes and narratives emerged from...
Team Madhav V. Rajan, MS, PhD Steven S. Wymer Dean, Chicago Booth; Distinguished Service Professor of Accounting, Chicago Booth; Chief Global Strategist, University of Chicago Steven S. Wymer Dean, Chicago Booth; Distinguished Service Professor of Accounting, Chicago Booth; Chief Global Strategist, University of Chicago
Program 2025-26 Program Sponsors Edward L. Kaplan, ’71* FIRST PLACE PRIZE Rattan L. Khosa, ’79 PLATINUM Jim and Karen Frank Venetia Kontogouris, MBA ’77 Gregory J. Purcell, ’94, and Francine C. Purcell Robert Vishny...
Page Mentorship Program The mentorship program is a valuable resource offered at the Polsky Center in which entrepreneurs and business owners meet one-on-one with industry leaders. Our mentors bring decades of experience in...
Team Nadya Mason, PhD Vice President for Research and Robert J. Zimmer Professor of Molecular Engineering, University of Chicago Vice President for Research and Robert J. Zimmer Professor of Molecular Engineering, University of Chicago
Technology New Antibiotics and Antibiotic Potentiators for Treating Staphylococcus Aureus Infections Methicillin-resistant Staphylococcus aureus (MRSA) infection is the leading cause of skin and soft tissue infections that affect nearly 30% of healthy adults. Staph infections can escalate in intensity if introduced to…
Technology Novel Compounds for the Potentiation of Antibiotic Resistance in Staphylococcus Aureus Currently there is no available vaccine for the prophylaxis of S. Aureus mediated infections such as MRSA, and antibiotics such as beta lactams and oxacillin are most commonly used for…
News U of C to Invest $25 Million in Startups University of Chicago is increasing its efforts to spin out more startups with a commitment to invest $25 million from its endowment to fund new companies launched by faculty, staff,...
News Innovation Fund Invests $500,000 in Health and Energy Companies The University of Chicago Innovation Fund announced plans to invest up to $500,000 into two companies—Cephalgia Therapeutics and RWEDI water—that are working to combat migraines and increase water efficiency, respectively....
News 2017 Americas Alternative Finance Industry Survey The Polsky Center for Entrepreneurship and Innovation and Booth School of Business at the University of Chicago and the Cambridge Centre for Alternative Finance at the University of Cambridge Judge...
